Zinger Key Points
- Core Scientific appoints Jim Nygaard as CFO, effective March 17, 2025, succeeding Denise Sterling.
- Nygaard brings 30 years of investment banking experience, focusing on M&A and corporate finance.
- Every week, our Whisper Index uncovers five overlooked stocks with big breakout potential. Get the latest picks today before they gain traction.
Core Scientific, Inc. CORZ shares are trading higher on Monday after the company disclosed that Jim Nygaard will take over as Executive Vice President and Chief Financial Officer on March 17, 2025.
This appointment is part of the previously disclosed CFO transition plan, with Jim Nygaard succeeding Denise Sterling.
Core Scientific noted Sterling was promoted to CFO shortly before the company filed for Chapter 11, playing a vital role in stabilizing and repositioning the company. Core Scientific emerged from Chapter 11 early last year.
Nygaard has nearly 30 years of investment banking experience, specializing in M&A, corporate finance, and capital raising. Since 2008, he has been Managing Director and Head of M&A at XMS Capital Partners, advising clients on strategic transactions and financing.
From 2021 to 2022, Nygaard served as Chief Financial Officer of Power & Digital Infrastructure Acquisition Corp., which merged with Core Scientific.
Prior to XMS Capital, Nygaard spent 12 years in Morgan Stanley‘s Investment Banking Division.
Adam Sullivan, Chief Executive Officer of Core Scientific, said, “As a premier digital infrastructure provider for high-performance computing, we believe Jim’s deep background in corporate finance and M&A will help us continue scaling our operations.”
”His proven ability to drive growth and shareholder value will be an invaluable asset during this pivotal stage of our evolution.”
Last month, the company expanded its partnership with AI hyperscaler CoreWeave. The new agreement adds $1.2 billion in contracted revenue at Core Scientific’s Denton, TX location, reinforcing the company’s role as a top provider of application-specific data centers for HPC workloads.
Also, Core Scientific recently reported a fourth-quarter adjusted loss of $(0.13), missing the estimate of $(0.08), with sales of $94.92 million, falling short of consensus of $99.92 million.
Investors can gain exposure to the stock via CoinShares Valkyrie Bitcoin Miners ETF WGMI and Global X Blockchain ETF BKCH.
Price Action: CORZ shares are up 1.79% at $11.36 at the last check Monday.
Photo Courtesy: Robert Way On Shutterstock.com.
Read Next:
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.